Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 2,298 shares at $62.20 ($143K) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $143k NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.20 | 1,149 | $71K | 50.0% |
| 2 | $62.20 | 1,149 | $71K | 50.0% |
| Total | $62.20 avg | 2,298 | $143K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |